Emirates NBD have commenced a phased implementation to adopt GSS’s network-driven sanctions screening solution for its ...

HR Asia, a brand under Business Media International proudly marks the 10th anniversary of its prestigious "HR Asia Best ...

Lydia Polgreen and Nicholas Kristof discuss why other nations are picking up what the president is punching down.

This article will examine how the chipmakers compare in terms of Quant Factor Grades and how TSM’s more compelling valuation ...

Youdao, Inc. ("Youdao" or the "Company") , an AI-powered solutions provider specializing in artificial intelligence applications for the learning and advertising verticals, today announced its ...

Hakkini plans to recruit over 50 certified clinicians by end of 2026 as UAE demand for science-based mental healthcare ...

Disney announced its first theme park in the Middle East is coming to Abu Dhabi. Fans haven’t just been guessing about the ...

Catalysts anchor Julie Hyman and guest host, Great Hill Capital chairman and managing member Thomas Hayes, cover a wide array ...

Microsoft began laying off about 6,000 workers Tuesday, its largest job cuts in more than two years as the company spends ...

MEGA PRIME FOODS, Inc. is targeting an initial public offering (IPO) within the next two to three years as part of its long-term growth strategy, while seeking to expand its sardines market share this ...

Ten other cabinet positions were named at the junior rank of secretaries of state, yet the new AI Minister, Evan Solomon, ...

About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.